Horvath, K; Bock, G; Regittnig, W; Bodenlenz, M; Wutte, A; Theobald, K; Schweitzer, MA; Fuerstrecktenwald, S; Pieber, TR.
Insulin glulisine, insulin lispro and regular human insulin show comparable end-organ metabolic effects in type 1 diabetes underlining physiologic insulin signaling
DIABETES. 2005; 54: A332-A332.
Web of Science